Suppr超能文献

血液透析期间肝素的药代动力学。

Heparin pharmacokinetics during hemodialysis.

作者信息

Kandrotas R J, Gal P, Douglas J B, Deterding J

机构信息

Department of Pharmacy, Greensboro Area Health Education Center, Moses H. Cone Memorial Hospital, North Carolina.

出版信息

Ther Drug Monit. 1989 Nov;11(6):674-9. doi: 10.1097/00007691-198911000-00011.

Abstract

The disposition of heparin was studied in 21 chronic hemodialysis patients. Heparin was administered as a bolus injection in doses of 3,000-12,000 U. Combined zero and first-order elimination was demonstrated, with heparin half-life declining by 74% over 3.5 h during dialysis. Assumption of a first-order pharmacokinetic model of elimination resulted in a mean difference of 0.001 U/ml between actual and predicted heparin concentrations. Mean first-order pharmacokinetic parameters were: half-life, 117 min; heparin volume of distribution (V), 68 ml/kg; clearance, 28 ml/min. A high degree of interpatient variability was also observed. A comparison of V and plasma volume (PV) revealed V to be significantly greater than PV (p less than 0.001), indicating distribution outside the plasma compartment. When compared to blood volume, there was no significant difference (p greater than 0.1), indicating that blood volume may be used to approximate V. The nonlinear component of the elimination process is not clinically significant within the range of therapeutic plasma concentrations used during hemodialysis, but the high degree of interpatient variability indicates that dosage individualization may be useful.

摘要

对21例慢性血液透析患者的肝素处置情况进行了研究。肝素以3000 - 12000 U的剂量静脉推注给药。研究显示肝素的消除呈零级和一级消除相结合的方式,在透析过程中,肝素半衰期在3.5小时内下降了74%。采用一级消除药代动力学模型进行假设,实际肝素浓度与预测肝素浓度之间的平均差异为0.001 U/ml。平均一级药代动力学参数为:半衰期117分钟;肝素分布容积(V)68 ml/kg;清除率28 ml/分钟。还观察到患者间存在高度变异性。V与血浆容积(PV)的比较显示,V显著大于PV(p < 0.001),表明分布于血浆室之外。与血容量相比,无显著差异(p > 0.1),这表明血容量可用于近似V。在血液透析期间使用的治疗性血浆浓度范围内,消除过程的非线性成分在临床上并不显著,但患者间的高度变异性表明剂量个体化可能是有用的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验